Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
- T42.2X6SBillable
Underdosing of succinimides and oxazolidinediones, sequela
- T42.3X5ABillable
Adverse effect of barbiturates, initial encounter
- T42.3X5DBillable
Adverse effect of barbiturates, subsequent encounter
- T42.3X5SBillable
Adverse effect of barbiturates, sequela
- T42.3X6ABillable
Underdosing of barbiturates, initial encounter
- T42.3X6DBillable
Underdosing of barbiturates, subsequent encounter
- T42.3X6SBillable
Underdosing of barbiturates, sequela
- T42.4X5ABillable
Adverse effect of benzodiazepines, initial encounter
- T42.4X5DBillable
Adverse effect of benzodiazepines, subsequent encounter
- T42.4X5SBillable
Adverse effect of benzodiazepines, sequela
- T42.4X6ABillable
Underdosing of benzodiazepines, initial encounter
- T42.4X6DBillable
Underdosing of benzodiazepines, subsequent encounter
- T42.4X6SBillable
Underdosing of benzodiazepines, sequela
- T42.5X5ABillable
Adverse effect of mixed antiepileptics, initial encounter
- T42.5X5DBillable
Adverse effect of mixed antiepileptics, subsequent encounter
- T42.5X5SBillable
Adverse effect of mixed antiepileptics, sequela
- T42.5X6ABillable
Underdosing of mixed antiepileptics, initial encounter
- T42.5X6DBillable
Underdosing of mixed antiepileptics, subsequent encounter
- T42.5X6SBillable
Underdosing of mixed antiepileptics, sequela
- T42.6X5ABillable
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.6X5DBillable
Adverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.6X5SBillable
Adverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
- T42.6X6ABillable
Underdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.6X6DBillable
Underdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.6X6SBillable
Underdosing of other antiepileptic and sedative-hypnotic drugs, sequela
- T42.75XABillable
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.75XDBillable
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.75XSBillable
Adverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
- T42.76XABillable
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.76XDBillable
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.76XSBillable
Underdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela
- T42.8X5ABillable
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
- T42.8X5DBillable
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
- T42.8X5SBillable
Adverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
- T42.8X6ABillable
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
- T42.8X6DBillable
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
- T42.8X6SBillable
Underdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela
- T43.015ABillable
Adverse effect of tricyclic antidepressants, initial encounter
- T43.015DBillable
Adverse effect of tricyclic antidepressants, subsequent encounter
- T43.015SBillable
Adverse effect of tricyclic antidepressants, sequela
- T43.016ABillable
Underdosing of tricyclic antidepressants, initial encounter
- T43.016DBillable
Underdosing of tricyclic antidepressants, subsequent encounter
- T43.016SBillable
Underdosing of tricyclic antidepressants, sequela
- T43.025ABillable
Adverse effect of tetracyclic antidepressants, initial encounter
- T43.025DBillable
Adverse effect of tetracyclic antidepressants, subsequent encounter
- T43.025SBillable
Adverse effect of tetracyclic antidepressants, sequela
- T43.026ABillable
Underdosing of tetracyclic antidepressants, initial encounter
- T43.026DBillable
Underdosing of tetracyclic antidepressants, subsequent encounter
- T43.026SBillable
Underdosing of tetracyclic antidepressants, sequela
- T43.1X5ABillable
Adverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X5DBillable
Adverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X5SBillable
Adverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.1X6ABillable
Underdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X6DBillable
Underdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X6SBillable
Underdosing of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.205ABillable
Adverse effect of unspecified antidepressants, initial encounter
- T43.205DBillable
Adverse effect of unspecified antidepressants, subsequent encounter
- T43.205SBillable
Adverse effect of unspecified antidepressants, sequela
- T43.206ABillable
Underdosing of unspecified antidepressants, initial encounter
- T43.206DBillable
Underdosing of unspecified antidepressants, subsequent encounter
- T43.206SBillable
Underdosing of unspecified antidepressants, sequela
- T43.215ABillable
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.215DBillable
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.215SBillable
Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.216ABillable
Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.216DBillable
Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.216SBillable
Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.225ABillable
Adverse effect of selective serotonin reuptake inhibitors, initial encounter
- T43.225DBillable
Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter
- T43.225SBillable
Adverse effect of selective serotonin reuptake inhibitors, sequela
- T43.226ABillable
Underdosing of selective serotonin reuptake inhibitors, initial encounter
- T43.226DBillable
Underdosing of selective serotonin reuptake inhibitors, subsequent encounter
- T43.226SBillable
Underdosing of selective serotonin reuptake inhibitors, sequela
- T43.295ABillable
Adverse effect of other antidepressants, initial encounter
- T43.295DBillable
Adverse effect of other antidepressants, subsequent encounter
- T43.295SBillable
Adverse effect of other antidepressants, sequela
- T43.296ABillable
Underdosing of other antidepressants, initial encounter
- T43.296DBillable
Underdosing of other antidepressants, subsequent encounter
- T43.296SBillable
Underdosing of other antidepressants, sequela
- T43.3X5ABillable
Adverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X5DBillable
Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X5SBillable
Adverse effect of phenothiazine antipsychotics and neuroleptics, sequela
- T43.3X6ABillable
Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X6DBillable
Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X6SBillable
Underdosing of phenothiazine antipsychotics and neuroleptics, sequela
- T43.4X5ABillable
Adverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X5DBillable
Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X5SBillable
Adverse effect of butyrophenone and thiothixene neuroleptics, sequela
- T43.4X6ABillable
Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X6DBillable
Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X6SBillable
Underdosing of butyrophenone and thiothixene neuroleptics, sequela
- T43.505ABillable
Adverse effect of unspecified antipsychotics and neuroleptics, initial encounter
- T43.505DBillable
Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.505SBillable
Adverse effect of unspecified antipsychotics and neuroleptics, sequela
- T43.506ABillable
Underdosing of unspecified antipsychotics and neuroleptics, initial encounter
- T43.506DBillable
Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.506SBillable
Underdosing of unspecified antipsychotics and neuroleptics, sequela
- T43.595ABillable
Adverse effect of other antipsychotics and neuroleptics, initial encounter
- T43.595DBillable
Adverse effect of other antipsychotics and neuroleptics, subsequent encounter
- T43.595SBillable
Adverse effect of other antipsychotics and neuroleptics, sequela
